InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by MCDONNELL MICHAEL R, Chief Financial Officer. Director active across 2 companies, notably BIOGEN INC.. Cumulatively, 4 filings have been logged. The latest transaction was disclosed on 24 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
03,050 shares0
Common Stock, No Par Value
SEC:0001415889-22-005723:0·
01,981 shares0
Common Stock
SEC:0001127602-22-006275:0·
€765,8382,681 shares@ €285.6538100.0% of flow
Common Stock
SEC:0001127602-21-024863·
€765,8382,681 shares@ €285.65380.0027% mcap50.0% of flow
Common Stock
SEC:0001127602-21-024863:0·
4 of 4 declarations
About MCDONNELL MICHAEL R
Michael R. McDonnell is the Chief Financial Officer and Executive Vice President of Biogen Inc. and Merit Medical Systems Inc. He is responsible for financial management and strategic financial planning for the companies. With extensive experience in finance, he plays a key role in strategic decision-making and optimizing financial performance. His expertise contributes to the growth and sustainability of companies in the biotechnology and medical device sectors.
